⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
INCY News
Incyte Genomics Inc
Immunoassay Market Research, Strategies, Trends and Forecasts Report 2025 with Executive Guides and Impact of Artificial Intelligence - ResearchAndMarkets.com
businesswire.com
ALGN
AMZN
BDX
BIO
BMY
CDNS
CERN
CHKP
CLVS
CODX
CRSP
CYTK
DELL
DGX
DHR
DIS
DTC
DXCM
ENZ
EXAS
FSLR
GILD
GOOG
IDXX
ILMN
INCY
INTC
ISRG
JNJ
LULU
LUMX
MDLZ
MRNA
MSFT
MYL
NBIX
NCLH
NFLX
NVS
NVTA
ORCL
ORGO
OSIP
OTIS
PANW
PFE
PG
PGR
PPC
PRGO
QCOM
QGEN
QORV
QUID
REGN
ROCH
ROST
SGEN
SIRI
SNPS
SPLK
SRPT
SWKS
SYK
TCOM
TEAM
TEVA
TGT
TMO
TSLA
TXN
ULTA
UNH
VRTX
WBA
WDC
WEC
WFC
XRAY
XTRA
ZBRA
Vitiligo Market Analysis and Forecasts 2025-2035 Featuring Abbvie, Incyte, Amgen, Pfizer, Clinuvel Pharmaceuticals, TWi Biotech, and Arcutis Biotherapeutics - ResearchAndMarkets.com
businesswire.com
ABBV
INCY
AMGN
PFE
ACRT
Incyte to Present at Upcoming Investor Conferences
businesswire.com
INCY
Incyte’s Moments of Clarity Program Expands to Highlight Powerful Patient Stories in Vitiligo and Pediatric Eczema
businesswire.com
INCY
Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting
businesswire.com
INCY
Incyte to Present at Upcoming Investor Conferences
businesswire.com
INCY
Incyte Reports Third Quarter 2025 Financial Results and Provides Business Updates
businesswire.com
INCY
Incyte and Enable Injections Announce Strategic Partnership for enFuse ® On-Body Delivery System
businesswire.com
INCY
Incyte Announces New Data from Phase 3b TRuE-AD4 Trial of Opzelura ® (Ruxolitinib Cream) in Adults with Moderate Atopic Dermatitis
businesswire.com
INCY
Lilly's baricitinib delivered near-complete scalp hair regrowth at one year for adolescents with severe alopecia areata in Phase 3 BRAVE-AA-PEDS trial
prnewswire.com
LLY
INCY